Curegenix Corporation
1 known investors
Find your way into Curegenix Corporation
Curegenix is a clinical-stage biopharmaceutical company founded in 2009 that develops small-molecule drugs targeting the WNT signaling pathway, including lead candidate CGX1321, for cancer and tissue repair, with operations in California and Guangzhou, China.
Investors · 1
Frequently asked questions
- What does Curegenix Corporation do?
- Curegenix is a clinical-stage biopharmaceutical company founded in 2009 that develops small-molecule drugs targeting the WNT signaling pathway, including lead candidate CGX1321, for cancer and tissue repair, with operations in California and Guangzhou, China.
- Who are Curegenix Corporation's investors?
- Curegenix Corporation's investors include F-Prime Capital.